1. 451PThe safety of ramucirumab without H1-antihistamines as a premedication in patients with solid cancers: A retrospective study. (24th November 2019) Authors: Hattori, N; Yamaguchi, T; Kodama, H; Miyamoto, T; Terazawa, T; Kii, T; Gotoh, E; Gotoh, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 467PProspective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer. (23rd October 2018) Authors: Masuishi, T; Suzuki, T; Sukawa, Y; Imamura, C K; Satake, H; Kumekawa, Y; Funakoshi, S; Kotaka, M; Horie, Y; Kawai, S; Okuda, H; Terazawa, T; Kondoh, C; Kato, K; Yoshimura, K; Ishikawa, H; Hamamoto, Y; Boku, N; Kanai, T; Takaishi, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0044 The inhibitory effects of tacrolimus on gliostatin production in ra synoviocytes. (15th June 2017) Authors: Ikuta, K; Waguri-Nagaya, Y; Yamagami, T; Tatematsu, N; Kawaguchi, Y; Oguri, Y; Terazawa, T; Kobayashi, M; Asai, K; Otsuka, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗